Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120102173 | 12010217 | 3 | F | 20160802 | 20160205 | 20160812 | EXP | US-BAYER-2016-021835 | BAYER | 0.00 | E | M | Y | 74.83000 | KG | 20160812 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120102173 | 12010217 | 1 | PS | AVELOX | MOXIFLOXACIN HYDROCHLORIDE | 1 | 400 MG, UNK | 21085 | 400 | MG | FILM-COATED TABLET | ||||||||
| 120102173 | 12010217 | 2 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | UNK | 0 | TABLET | ||||||||||
| 120102173 | 12010217 | 3 | SS | LEVAQUIN | LEVOFLOXACIN | 1 | UNK | 0 | |||||||||||
| 120102173 | 12010217 | 4 | SS | CIPROFLOXACIN. | CIPROFLOXACIN | 1 | 500 MG, UNK | 0 | 500 | MG | |||||||||
| 120102173 | 12010217 | 5 | C | DOXAZOSIN | DOXAZOSINDOXAZOSIN MESYLATE | 1 | 4 MG, QD | 0 | 4 | MG | QD | ||||||||
| 120102173 | 12010217 | 6 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | UNK | 0 | |||||||||||
| 120102173 | 12010217 | 7 | C | IBUPROFEN AL | IBUPROFEN | 1 | UNK | 0 | |||||||||||
| 120102173 | 12010217 | 8 | C | SIMVASTATIN. | SIMVASTATIN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120102173 | 12010217 | 5 | Benign prostatic hyperplasia |
| 120102173 | 12010217 | 6 | Depression |
| 120102173 | 12010217 | 7 | Arthritis |
| 120102173 | 12010217 | 8 | Blood cholesterol |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 120102173 | 12010217 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120102173 | 12010217 | Cardiovascular disorder | |
| 120102173 | 12010217 | Mental disorder | |
| 120102173 | 12010217 | Musculoskeletal injury | |
| 120102173 | 12010217 | Nerve injury | |
| 120102173 | 12010217 | Nervous system disorder | |
| 120102173 | 12010217 | Neuropathy peripheral | |
| 120102173 | 12010217 | Pain | |
| 120102173 | 12010217 | Skin injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120102173 | 12010217 | 1 | 20090307 | 0 | ||
| 120102173 | 12010217 | 4 | 20081104 | 20081104 | 0 | |
| 120102173 | 12010217 | 6 | 2013 | 0 | ||
| 120102173 | 12010217 | 7 | 2010 | 0 | ||
| 120102173 | 12010217 | 8 | 2012 | 0 |